These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 21357829)

  • 1. Life imitates art: anti-amyloid antibodies and inflammatory cerebral amyloid angiopathy.
    Greenberg SM; Frosch MP
    Neurology; 2011 Mar; 76(9):772-3. PubMed ID: 21357829
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-Aβ Antibodies and Cerebral Amyloid Angiopathy Complications.
    Chantran Y; Capron J; Alamowitch S; Aucouturier P
    Front Immunol; 2019; 10():1534. PubMed ID: 31333665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel strategies for Alzheimer's disease treatment: An overview of anti-amyloid beta monoclonal antibodies.
    Rygiel K
    Indian J Pharmacol; 2016; 48(6):629-636. PubMed ID: 28066098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AD vaccines: conclusions and future directions.
    Wisniewski T
    CNS Neurol Disord Drug Targets; 2009 Apr; 8(2):160-6. PubMed ID: 19355935
    [No Abstract]   [Full Text] [Related]  

  • 5. Bapineuzumab in Alzheimer's disease: where now?
    Wilcock GK
    Lancet Neurol; 2010 Feb; 9(2):134-6. PubMed ID: 20129159
    [No Abstract]   [Full Text] [Related]  

  • 6. Vaccines: chasing the dream.
    Schnabel J
    Nature; 2011 Jul; 475(7355):S18-9. PubMed ID: 21760578
    [No Abstract]   [Full Text] [Related]  

  • 7. Off-label use of aducanumab for cerebral amyloid angiopathy.
    Greenberg SM; Cordonnier C; Schneider JA; Smith EE; van Buchem MA; van Veluw SJ; Verbeek MM; Viswanathan A; Werring DJ
    Lancet Neurol; 2021 Aug; 20(8):596-597. PubMed ID: 34237272
    [No Abstract]   [Full Text] [Related]  

  • 8. Vessels Sing Their ARIAs: The Role of Vascular Amyloid in the Age of Aducanumab.
    Sveikata L; Charidimou A; Viswanathan A
    Stroke; 2022 Jan; 53(1):298-302. PubMed ID: 34905943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prodromal Alzheimer's disease presenting as cerebral amyloid angiopathy-related inflammation with spontaneous amyloid-related imaging abnormalities and high cerebrospinal fluid anti-Aβ autoantibodies.
    Boncoraglio GB; Piazza F; Savoiardo M; Farina L; DiFrancesco JC; Prioni S; Tagliavini F; Parati EA; Giaccone G
    J Alzheimers Dis; 2015; 45(2):363-7. PubMed ID: 25537009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APOE {epsilon}4 and bapineuzumab: Infusing pharmacogenomics into Alzheimer disease therapeutics.
    Kaufer D; Gandy S
    Neurology; 2009 Dec; 73(24):2052-3. PubMed ID: 19923549
    [No Abstract]   [Full Text] [Related]  

  • 11. Alzheimer's drugs take a new tack.
    Callaway E
    Nature; 2012 Sep; 489(7414):13-4. PubMed ID: 22962697
    [No Abstract]   [Full Text] [Related]  

  • 12. Low avidity and level of serum anti-Aβ antibodies in patients with cerebral amyloid angiopathy-related cerebral hemorrhage.
    Cao Z; Lv J; Quan W
    Int J Neurosci; 2010 Dec; 120(12):760-4. PubMed ID: 20954837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vaccination against Alzheimer disease?].
    Blasko I; Grubeck-Loebenstein B
    Wien Klin Wochenschr; 2003 May; 115(9):279-80. PubMed ID: 12793027
    [No Abstract]   [Full Text] [Related]  

  • 14. Amyloid antibody therapy for early-stage Alzheimer's disease: a critical review of three recent trials.
    Guiloff AE; Rudge P
    J Neurol; 2024 May; 271(5):2914-2916. PubMed ID: 38613568
    [No Abstract]   [Full Text] [Related]  

  • 15. Gantenerumab for the treatment of Alzheimer's disease.
    Delrieu J; Ousset PJ; Vellas B
    Expert Opin Biol Ther; 2012 Aug; 12(8):1077-86. PubMed ID: 22583155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid beta peptide immunotherapy in Alzheimer disease.
    Delrieu J; Ousset PJ; Voisin T; Vellas B
    Rev Neurol (Paris); 2014 Dec; 170(12):739-48. PubMed ID: 25459121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A human monoclonal IgG that binds aβ assemblies and diverse amyloids exhibits anti-amyloid activities in vitro and in vivo.
    Levites Y; O'Nuallain B; Puligedda RD; Ondrejcak T; Adekar SP; Chen C; Cruz PE; Rosario AM; Macy S; Mably AJ; Walsh DM; Vidal R; Solomon A; Brown D; Rowan MJ; Golde TE; Dessain SK
    J Neurosci; 2015 Apr; 35(16):6265-76. PubMed ID: 25904780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoimmune responses to amyloid structures of Abeta(25-35) peptide and human lysozyme in the serum of patients with progressive Alzheimer's disease.
    Gruden MA; Davudova TB; Malisauskas M; Zamotin VV; Sewell RD; Voskresenskaya NI; Kostanyan IA; Sherstnev VV; Morozova-Roche LA
    Dement Geriatr Cogn Disord; 2004; 18(2):165-71. PubMed ID: 15211072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bapineuzumab.
    Kerchner GA; Boxer AL
    Expert Opin Biol Ther; 2010 Jul; 10(7):1121-30. PubMed ID: 20497044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bapineuzumab: anti-β-amyloid monoclonal antibodies for the treatment of Alzheimer's disease.
    Panza F; Frisardi V; Imbimbo BP; D'Onofrio G; Pietrarossa G; Seripa D; Pilotto A; Solfrizzi V
    Immunotherapy; 2010 Nov; 2(6):767-82. PubMed ID: 21091109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.